Other DNA-damaging chemotherapeutics such as anthracyclines (idarubicin and doxorubicin) are able to induce the exposure or the release of DAMPs inducing the surface translocation of calreticulin or the release of high-mobility group box 1 (HMGB1) in dying tumor cells, both signals inducing the recruitment and the activation of DCs [39,40]. This evidence concerns the gene HMGB1 and neoplasm.